Details of the Drug

General Information of Drug (ID: DMCXTM0)

• Drug Name: SB623

Indication

Disease Entry	ICD 11	Status	REF
Ischemic stroke	8B11.5Z	Phase 2	[1]
Traumatic brain injury	NA07.Z	Phase 2	[2]

• Drug Type: Cell therapy
• Cross-matching ID: TTD ID: D9OS5I
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] ClinicalTrials.gov (NCT02448641) Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke (ACTIsSIMA). U.S. National Institutes of Health.
• [2] ClinicalTrials.gov (NCT02416492) A Study of Modified Stem Cells in Traumatic Brain Injury (TBI) (STEMTRA). U.S. National Institutes of Health.